Clinico-epidemiological nature and antibiotic susceptibility profile of Acinetobacter species

被引:6
作者
Biglari, Shirin [1 ]
Hanafiah, Alfizah [1 ]
Ramli, Ramliza [1 ]
Rahman, Md. Mostafizur [1 ]
Khaithir, Tzar Mohd Nizam [1 ]
机构
[1] Univ Kebangsaan Malaysia, Dept Med Microbiol & Immunol, Med Ctr, Kuala Lumpur, Malaysia
关键词
Acinetobacter spp; Antimicrobial susceptibility; Intensive care unit; Polymyxin B; HOSPITAL-ACQUIRED INFECTIONS; RISK-FACTORS; ANTIMICROBIAL RESISTANCE; BAUMANNII; ACQUISITION; OUTBREAK; MALAYSIA; OPTIONS; TRENDS; IMPACT;
D O I
10.12669/pjms.292.3132
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Acinetobacter spp. has emerged as an important opportunistic pathogen responsible for nosocomial infections in many health-care settings worldwide. The study describes the clinico-epidemiology and antimicrobial susceptibility of Acinetobacter spp. in a tertiary health-care institution. Methodology: Acinetobacter spp. were isolated from 141 specimens of the patients who reported to Universiti Kebangsaan Medical Centre (UKMMC). The sources of specimens were wound, skin and soft tissue, respiratory and urinary tract from patients in various wards. Clinio-epidemiological features of patients infected with Acinetobacter spp. were recorded. Standard bacteriological techniques with API 20NE kits and disk diffusion method were followed for identification and antibiotic sensitivity of the organisms. Results: One hundred and forty one patients with positive culture for Acinetobacter spp. were identified. Soft tissue/wound and respiratory tract were among the commonest sites of Acinetobacter spp. isolation. The isolates were most frequently obtained from ICU. All isolates were multi-drug resistant and had a resistance rate of more than 70% to most antibiotics, except polymyxin B. Conclusion: High prevalence of multi-drug resistance Acinetobacter spp. provides essential information on judicious antibiotic selection for empirical therapy in our health-care institution.
引用
收藏
页码:469 / 473
页数:5
相关论文
共 23 条
  • [1] Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections
    Baran, Guelseren
    Erbay, Ayse
    Bodur, Huerrem
    Onguru, Pinar
    Akinci, Esraguel
    Balaban, Neriman
    Cevik, Mustafa A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (01) : 16 - 21
  • [2] The "Zero Risk" Concept for Hospital-Acquired Infections: A Risky Business!
    Carlet, Jean
    Fabry, Jacques
    Amalberti, Rene
    Degos, Laurent
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 49 (05) : 747 - 749
  • [3] Nosocomial Outbreak of Infection With Multidrug-Resistant Acinetobacter baumannii in a Medical Center in Taiwan
    Chang, Hui-Lan
    Tang, Chih-Hsin
    Hsu, Yuan-Man
    Wan, Lei
    Chang, Ya-Fen
    Lin, Chiung-Tsung
    Tseng, Yao-Ru
    Lin, Ying-Ju
    Sheu, Jim Jinn-Chyuan
    Lin, Cheng-Wen
    Chang, Yun-Chieh
    Ho, Mao-Wang
    Lin, Chia-Der
    Ho, Cheng-Mao
    Lai, Chih-Ho
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (01) : 34 - 38
  • [4] Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain:: a nationwide study
    Cisneros, JM
    Rodríguez-Baño, J
    Fernández-Cuenca, F
    Ribera, A
    Vila, J
    Pascual, A
    Martínez-Martínez, L
    Bou, G
    Pachón, J
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (11) : 874 - 879
  • [5] Clinical and Laboratory Standards Institute, M100S17 CLSI
  • [6] Deris ZZ, 2009, TROP BIOMED, V26, P123
  • [7] Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK
    Enoch, D. A.
    Summers, C.
    Brown, N. M.
    Moore, L.
    Gillham, M. I.
    Burnstein, R. M.
    Thaxter, R.
    Enoch, L. M.
    Matta, B.
    Sule, O.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2008, 70 (02) : 109 - 118
  • [8] Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications
    Falagas, M. E.
    Mourtzoukou, E. G.
    Polemis, M.
    Vatopoulos, A. C.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (08) : 816 - 819
  • [9] Clinical and economic impact of common multidrug-resistant gram-negative bacilli
    Giske, Christian G.
    Monnet, Dominique L.
    Cars, Otto
    Carmeli, Yehuda
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (03) : 813 - 821
  • [10] Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options
    Kempf, Marie
    Rolain, Jean-Marc
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (02) : 105 - 114